Continuous data for better studies

Clinical research needs data from real life - not just from controlled study environments. Use the SaniQ OS telemedicine platform to continuously collect high-quality real-world data from the everyday lives of your test subjects.

3 Challenges in clinical studies:

Continuously generate high-quality data

Reduce the dropout rate

Communicate efficiently

How SaniQ supports you:

1. continuous data

What used to be recorded as isolated data points in sterile practice rooms becomes a vivid picture of the course of symptoms in everyday life with SaniQ.

This is how SaniQ accompanies your test subjects through everyday life:

1. In the morning, they measure their vital signs at home using sensors connected to SaniQ.

2. At lunchtime, they answer digital questionnaires about their symptoms via the SaniQ patient app.

3. In the evening, they document how the new therapy affects their quality of life.

SaniQ transforms every day of study participation into valuable real-world data that you can track in real time via the SaniQ Dashboard.

2. better compliance

SaniQ makes study participation much more convenient for test subjects:

They measure their vital signs from the comfort of their own home, answer digital questionnaires (PREMs & PROMs) when it suits them and receive gentle reminders via the patient app if they forget something. Should any questions arise, they can communicate immediately via the platform via chat or video consultation instead of waiting for the next appointment.

This flexibility means that significantly fewer participants terminate the study prematurely and the data quality increases noticeably due to more consistent participation.

3. more efficient therapy control

Make treatment decisions when they are needed:

SaniQ notifies you directly when a test subject sends abnormal values. With just a few clicks, you can then view the current vital signs, evaluate questionnaire data and discuss the next steps via chat or video consultation without the patient first having to make an appointment or travel to the centre.

This ability to react quickly makes it possible to adapt the therapy efficiently and precisely to the course of symptoms, while at the same time ensuring complete documentation for the study data.

1. continuous data

This is how you accompany test subjects through their everyday life with SaniQ:

In the morning, they measure their vital signs at home using sensors connected to SaniQ.
At lunchtime, they answer digital questionnaires about their symptoms via the SaniQ patient app.
In the evening, they document how the new therapy affects their quality of life.

SaniQ transforms every day of study participation into valuable real-world data that you can track in real time via the SaniQ Dashboard.

What used to be recorded as isolated data points in sterile practice rooms becomes a vivid picture of the course of symptoms in everyday life.

2. better compliance

SaniQ makes study participation much more convenient for test subjects:

This flexibility means that significantly fewer participants terminate the study prematurely and the data quality increases noticeably due to more consistent participation.

3. more efficient therapy control

Make treatment decisions when they are needed:

This ability to react quickly makes it possible to adapt the therapy efficiently and precisely to the course of symptoms and at the same time ensure complete documentation for the study data.

Use case: DIKAP study

The DIKAP study "Digital Cardiovascular Prevention" is currently the largest study on cardiovascular primary prevention in Germany.

Information on the study

Period: 2025-2026

Partner: University Clinic for Cardiology and Angiology at Otto von Guericke University Magdeburg

Content: With the help of SaniQ, the study is investigating how digital solutions can contribute to the prevention of serious cardiovascular diseases.

The study combines various SaniQ modules:

Digital training courses: Participants receive comprehensive information on cardiovascular risk factors
Telemonitoring: Monitoring of blood pressure, weight & physical activity
Video consultation: Regular telemedical visits

Video

A TV report on the DIKAP study by MDR (19 May 2025):

Blog

Heart attack & stroke: Can telemedicine better protect patients at risk?

In a new pioneering study at Magdeburg University Hospital, a team of researchers led by Dr Patrick Müller is investigating how telemedicine can be used to better protect patients at risk ... Read more

Studies with SaniQ OS

SaniQ has already been used profitably in numerous clinical studies and research projects:

Heart attack & stroke: Can telemedicine better protect patients at risk?

A team of researchers led by Dr Patrick Müller is investigating how new telemedicine technologies can be used to improve the care of high-risk patients.

to the article

Telemonitoring for COPD in standard care?

Telementor-COPD is a multicentre, randomised and controlled clinical study funded by the Federal Joint Committee and led by LungenClinic Großhansdorf. With the help of SaniQ, it is investigating the benefits of telemonitoring for patients with COPD.

To the programme description

Telemedicine closes care gap

A team of doctors at Berlin's Charité hospital is breaking new ground to provide much-needed support to those affected by a neurological disease.

to the article

What researchers say about SaniQ

"The TIM-NIV study is investigating digital medical options for improving non-invasive home ventilation. SaniQ enables telemedical care for those affected by recording health-related data and transmitting it to the study centre in real time."

Dr Dirk Westhölter

Clinician Scientist at the Ruhrlandklinik Essen

"Qurasoft's technical support is simply worth its weight in gold for us, because we are happy to draw on their expertise and vast experience in the areas of IT, development, regulatory affairs, etc. For us, this is the perfect complement to our clinical expertise in the field of rare diseases. "

Dr Maike Stein

Physician and scientist at the integrated Myasthenia Centre (iMZ) at Charité Universitätsmedizin Berlin

"We get on very well with the SaniQ telemonitoring platform. The big advantage of telemonitoring is that I can organise when I look at the platform myself - it's just important that I (or a member of staff) find the time to do it once a day - and I do!"

Ralph Rüdelstein, MD

Chief Physician in the Department of Internal Medicine at St. Nikolaus Stiftshospital, Andernach

Request now: free live demo

In an interactive software demo, we will show you how our RPM platform SaniQ works and the benefits it offers.

Let's talk about your project idea!

Jonas Zimmer
-Project development-

Let's talk about your project idea!

Continuous data for better studies

3 Challenges in clinical studies:

3 Challenges in clinical studies:

Continuously generate high-quality data

Reduce the dropout rate

Communicate efficiently

How SaniQ supports you:

1. continuous data

2. better compliance

3. more efficient therapy control

Use case: DIKAP study

Studies with SaniQ OS

Heart attack & stroke: Can telemedicine better protect patients at risk?

Telemonitoring for COPD in standard care?

Telemedicine closes care gap

What researchers say about SaniQ

Arrange a SaniQ live demo

Company

Legal